Hedge fund titan David Tepper has made some key portfolio moves in Q2, as revealed by 13F forms filed with the SEC …
Valeant’s a Deep Shade of Grey All eyes are on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as the Street wonders if this troubled biotech …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) released a grim second quarter print last Thursday, revealing that the management team had lowered guidance across …
Is Teva Pharmaceutical a Falling Knife to Catch After Plunging over 30%? This week turned out to be a nightmare for shareholders of Teva …
Teva Falling Under Sends Oppenheimer to the Sidelines Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is looking at having to slash 7,000 jobs from …
Investors continue to dump shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after the pharmaceutical giant reported lower-than-expected second-quarter earnings. Specifically, Teva reported revenues …
Valeant’s Siliq Not Competitive Enough in Psoriasis Market Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) fighting chances in the drug arena to compete may have just …
Don’t Overvalue Valeant’s Recent Rally, Teva’s Momentum Waiting in Back Half of the Year
Top analyst Irina Rivkind Koffler at Mizuho is out today sounding the alarm on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) in a research report today, …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares are falling nearly 7% following CEO Erez Vigodman’s exit, leaving current chairman Dr. Yitzhak Peterburg to …